International Stem Cell Corporation announced that its Research and Development team has advanced its program to create a functional and transplantable human cornea by developing a new method to derive corneal endothelium-like cells from human pluripotent stem cells.
This work represents a significant step towards the creation of complete cornea tissue that can be used for transplantation and supports prior data showing indications of corneal endothelium generated by ISCO’s collaborators at Sankara Nethralaya Eye Hospital, India. Such cells by themselves may potentially promote wound healing and regeneration of the cornea and therefore could be used as a standalone medical treatment.
Breakthrough in Stem Cell Research for the Cornea
Stem Cell Research using the patient’s own Adult Stem Cells has brought us another great discovery- Stem Cell Contact Lens. In Australia, a group of doctors in a research study treated 3 patients who had some form of cornea problems and they all were able […]
A two-year-old Delhi boy suffering from thalassemia got a new lease of life after a Bangalorean donated his blood stem cells to him. This is the first reported case in India of a thalassemia patient receiving blood stem cells from an unrelated donor.
Garvit Goel was advised to go for a blood stem cell transplant a year ago. None of his family members qualified to be potential donors. That’s when Sumeet Mahjan, a software professional from MindTree, stepped in.
For Sumeet, the turning point came in 2011 when his colleague’s 11-year-old son was diagnosed with leukemia. MindTree requested Datri, an NGO
The rising cost of healthcare has been a cause of concern around the globe. The global economic crisis has seen governments such as the US and Japan attempting to minimise the cost of state-funded healthcare.
The increased prevalence of cardiovascular disorders, metabolic diseases, cancer, etc coupled with the emergence of more virulent forms of existing diseases poses a challenge for current medical therapies.
India is already seen as the world’s low-cost pharmacy as far as conventional therapies are concerned. And the recent economic and epidemiological changes present a lucrative opportunity for the Indian biotech industry to replicate this success in the
When others of her age played with dolls, eight-year-old Thamirabharani was taking blood transfusions.
Born with thalassaemia, she has, however, found hope. She was detected with the disease when she was a year and a half and has been undergoing regular blood transfusions since.
Haematologist Revathy Raj and his team from Apollo Gleneagles hospital in Chennai gave a new lease of life to the little girl from Coimbatore through stem cell transplantation. Doctors said she is now fully cured and has not needed a single transfusion since March.
Doctors claimed this is the first success story in India using the stem cells